BioCrude Technologies USA, Inc. Quarterly Return On Equity in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BioCrude Technologies USA, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q2 2024.
  • BioCrude Technologies USA, Inc. Return On Equity for the quarter ending June 30, 2024 was 119 %, a 19.1% decline year-over-year.
  • BioCrude Technologies USA, Inc. annual Return On Equity for 2023 was 118 %, a 16.6% increase from 2022.
  • BioCrude Technologies USA, Inc. annual Return On Equity for 2022 was 102 %, a 78.5% decline from 2021.
  • BioCrude Technologies USA, Inc. annual Return On Equity for 2021 was 472 %, a 328% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 119 -28.1 -19.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 137 +32.1 +30.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 118 +16.8 +16.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 124 +1.62 +1.32% Jul 1, 2023 Sep 30, 2023
Q2 2023 147 +34.2 +30.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 104 -144 -58% Jan 1, 2023 Mar 31, 2023
Q4 2022 102 -370 -78.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 123 Jul 1, 2022 Sep 30, 2022
Q2 2022 113 Apr 1, 2022 Jun 30, 2022
Q1 2022 249 Jan 1, 2022 Mar 31, 2022
Q4 2021 472 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.